200 related articles for article (PubMed ID: 10771008)
21. An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
Baakman AC; Alvarez-Jimenez R; Rissmann R; Klaassen ES; Stevens J; Goulooze SC; den Burger JCG; Swart EL; van Gerven JMA; Groeneveld GJ
Br J Clin Pharmacol; 2017 Aug; 83(8):1676-1687. PubMed ID: 28217868
[TBL] [Abstract][Full Text] [Related]
22. Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.
Amitai N; Markou A
Psychopharmacology (Berl); 2009 Jan; 202(1-3):275-86. PubMed ID: 18618099
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive deficits in performance of an attentional task produced by co-administering alcohol and nicotine to rats.
Bizarro L; Patel S; Stolerman IP
Drug Alcohol Depend; 2003 Dec; 72(3):287-95. PubMed ID: 14643946
[TBL] [Abstract][Full Text] [Related]
24. A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task.
Grottick AJ; Wyler R; Higgins GA
Pharmacol Biochem Behav; 2001 Dec; 70(4):505-13. PubMed ID: 11796150
[TBL] [Abstract][Full Text] [Related]
25. Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice.
Leblond L; Beaufort C; Delerue F; Durkin TP
Behav Brain Res; 2002 Jan; 128(1):91-102. PubMed ID: 11755693
[TBL] [Abstract][Full Text] [Related]
26. Effects of nicotine and mecamylamine on cognition in rhesus monkeys.
Katner SN; Davis SA; Kirsten AJ; Taffe MA
Psychopharmacology (Berl); 2004 Sep; 175(2):225-40. PubMed ID: 15112030
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.
Rezvani AH; Kholdebarin E; Cauley MC; Dawson E; Levin ED
Pharmacol Biochem Behav; 2009 Mar; 92(1):141-6. PubMed ID: 19041337
[TBL] [Abstract][Full Text] [Related]
28. Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention.
Bushnell PJ; Oshiro WM; Padnos BK
Psychopharmacology (Berl); 1997 Dec; 134(3):230-41. PubMed ID: 9438673
[TBL] [Abstract][Full Text] [Related]
29. The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task.
Blondel A; Simon H; Sanger DJ; Moser P
Behav Pharmacol; 1999 Nov; 10(6-7):665-73. PubMed ID: 10780508
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
[TBL] [Abstract][Full Text] [Related]
31. Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
Alvarez-Jimenez R; Hart EP; Prins S; de Kam M; van Gerven JMA; Cohen AF; Groeneveld GJ
Br J Clin Pharmacol; 2018 May; 84(5):888-899. PubMed ID: 29319910
[TBL] [Abstract][Full Text] [Related]
32. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task.
Hoyle E; Genn RF; Fernandes C; Stolerman IP
Psychopharmacology (Berl); 2006 Dec; 189(2):211-23. PubMed ID: 17019565
[TBL] [Abstract][Full Text] [Related]
33. The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats.
Ko T; Evenden J
Psychopharmacology (Berl); 2009 Jan; 202(1-3):67-78. PubMed ID: 18825373
[TBL] [Abstract][Full Text] [Related]
34. Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats.
Mendez IA; Gilbert RJ; Bizon JL; Setlow B
Psychopharmacology (Berl); 2012 Dec; 224(4):489-99. PubMed ID: 22760484
[TBL] [Abstract][Full Text] [Related]
35. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
[TBL] [Abstract][Full Text] [Related]
36. Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span task.
Rushforth SL; Allison C; Wonnacott S; Shoaib M
Neurosci Lett; 2010 Mar; 471(2):114-8. PubMed ID: 20083163
[TBL] [Abstract][Full Text] [Related]
37. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
Grundey J; Amu R; Ambrus GG; Batsikadze G; Paulus W; Nitsche MA
Psychopharmacology (Berl); 2015 Jul; 232(14):2491-501. PubMed ID: 25721074
[TBL] [Abstract][Full Text] [Related]
38. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor.
Young JW; Finlayson K; Spratt C; Marston HM; Crawford N; Kelly JS; Sharkey J
Neuropsychopharmacology; 2004 May; 29(5):891-900. PubMed ID: 14970827
[TBL] [Abstract][Full Text] [Related]
39. Limits of learning enhancements with nicotine in old male rats.
Taylor GT; Bassi CJ; Weiss J
Acta Neurobiol Exp (Wars); 2005; 65(2):125-36. PubMed ID: 15960296
[TBL] [Abstract][Full Text] [Related]
40. Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands.
Hahn B; Shoaib M; Stolerman IP
Psychopharmacology (Berl); 2002 Jul; 162(2):129-37. PubMed ID: 12110990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
